The US Food and Drug Administration (FDA) has authorised for marketing the first medical device to use artificial intelligence (AI) to detect diabetic retinopathy (DR).
23 April 2018
17 April 2018
On Wednesday 11 April the US Food and Drug Administration (FDA) announced the marketing approval of the first medical device to use artificial intelligence (AI) to detect more than a...
6 April 2018
A laboratory-developed test (LDT) is a type of in vitro diagnostic that, according to the FDA, must be designed, manufactured, and used all within the same laboratory. In the past,...
19 March 2018
Janssen Pharmaceutical Companies of Johnson & Johnson revealed ground-breaking results from a recent study, showing that wearable continuous electrocardiogram (ECG) monitoring patches were able to detect asymptomatic atrial fibrillation (AF)...
12 March 2018
Many research groups and private companies are attempting to develop a test that can accurately and effectively determine whether or not a person has cancer.
21 February 2018
Digital advances in ophthalmology are aimed at improving diagnosis. GlobalData identified three highlights for the ophthalmology market.
16 February 2018
A 2017 round-up of digital health advances in immunology highlights innovations around clinical trial design, patient compliance, and chronic disease management.
13 February 2018
An artificial intelligence (AI) network, DeepHeart, developed by Cardiogram, can use data from wearable devices to detect the early signs of diabetes, a study has found.
2 January 2018
At the outset of 2018, analysis of medical technology pipeline products shows a dynamic market, with particularly heavy investment into in vitro diagnostics (IVD).
21 December 2017
The general surgery market is forecast to grow steadily moving into the next decade—the market was valued at $14.6 billion in 2017 and is expected to reach a value of...